semaglutide side effect class action in kentucky glp-1 vomiting Zepbound Lawsuit [2026] kentucky glp-1 class – Kentucky Ozempic Lawsuit Lawyers |

Use of Ozempic, a GLP-1 medication approved by the Food and Drug Administration (FDA) to treat diabetes, is increasing 75% (or $6.7 billion in spending) on a rolling 12-month average.1 This type of snowballing drug spend, if left unchecked, can cause plan premiums to soar, potentially pricing out members, leaving people who need drug coverage without the ability to pay for it

Learn more Peptide Therapy Explore our full suite of therapeutic peptides for anti-aging, recovery, and performance optimization

Cell Commun Sign 11:118

presumably because of the increased release of GLP-1 following thylakoid supplementation

doi: 10.1146/annurev-physiol-020518-114455, 12